Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.

The New England journal of medicine - 18 Jun 1998

Martinelli I, Sacchi E, Landi G, Taioli E, Duca F, Mannucci P M

Abstract excerpt

BACKGROUND: Idiopathic cerebral-vein thrombosis can cause serious neurologic disability. We evaluated risk factors for this disorder, including genetic risk factors (mutations in the genes encoding factor V and prothrombin) and nongenetic risk factors (such as the use of oral contraceptive agents...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Case-Control Studies
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heterozygote

Share to Mutation

Share to Odds Ratio

Share to Prevalence

Share to Prothrombin

Source

Identifiers

PMID: 9632445
DOI: 10.1056/NEJM199806183382502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-9632445-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.PMID 9632445Read ↗

Inherited prothrombotic risk factors and cerebral venous thrombosis.Semantic proximity Read ↗

An unusual cause of cerebral venous sinus thrombosis: prothrombin G20210A gene mutation.Semantic proximity Read ↗

Case-control study of risk of cerebral sinus thrombosis in oral contraceptive users and in [correction of who are] carriers of hereditary prothrombotic conditions. The Cerebral Venous Sinus Thrombosis Study Group.Semantic proximity Read ↗

Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis.Semantic proximity Read ↗

Non-genetic and genetic risk factors for adult cerebral venous thrombosis.Semantic proximity Read ↗

Clinical significance of factor V Leiden and prothrombin G20210A-mutations in cerebral venous thrombosis - comparison with arterial ischemic stroke.Semantic proximity Read ↗

An Exploratory Study Using Next-Generation Sequencing to Identify Prothrombotic Variants in Patients with Cerebral Vein Thrombosis.Semantic proximity Read ↗

Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.Semantic proximity Read ↗

MTHFR Gene Polymorphisms and Cardiovascular Risk Factors, Clinical-Imagistic Features and Outcome in Cerebral Venous Sinus ThrombosisSemantic proximity Read ↗

Cerebral Thrombosis: A Neurogenetic Approach.Semantic proximity Read ↗

Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.Semantic proximity Read ↗

Antithrombin Cambridge II mutation as a risk factor to develop cerebral venous thrombosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.